113 related articles for article (PubMed ID: 38677766)
21. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis.
Oetzel D; Schraube P; Hensley F; Sroka-Pérez G; Menke M; Flentje M
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):455-60. PubMed ID: 7673033
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and Characteristics of Symptomatic Pneumonitis After Radiotherapy of Patients With Locally Advanced Lung Cancer.
Rades D; Glatzel E; Werner EM; Bohnet S
Anticancer Res; 2019 Dec; 39(12):6909-6913. PubMed ID: 31810961
[TBL] [Abstract][Full Text] [Related]
23. Lung Size and the Risk of Radiation Pneumonitis.
Briere TM; Krafft S; Liao Z; Martel MK
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):377-84. PubMed ID: 26675062
[TBL] [Abstract][Full Text] [Related]
24. The impact of heterogeneity correction on dosimetric parameters that predict for radiation pneumonitis.
Chang DT; Olivier KR; Morris CG; Liu C; Dempsey JF; Benda RK; Palta JR
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):125-31. PubMed ID: 16427214
[TBL] [Abstract][Full Text] [Related]
25. Correlation of dosimetric and clinical factors with the development of esophagitis and radiation pneumonitis in patients with limited-stage small-cell lung carcinoma.
Giuliani ME; Lindsay PE; Kwan JY; Sun A; Bezjak A; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ
Clin Lung Cancer; 2015 May; 16(3):216-20. PubMed ID: 25532963
[TBL] [Abstract][Full Text] [Related]
26. Radiation Pneumonitis After Volumetric Modulated Arc Therapy for Non-small Cell Lung Cancer.
Fujiwara M; Doi H; Igeta M; Suzuki H; Kitajima K; Tanooka M; Ishida T; Wakayama T; Yokoi T; Kuribayashi K; Kijima T; Hashimoto M; Kondo N; Matsumoto S; Hasegawa S; Kamikonya N; Yamakado K
Anticancer Res; 2021 Nov; 41(11):5793-5802. PubMed ID: 34732453
[TBL] [Abstract][Full Text] [Related]
27. Predictors of Pneumonitis After Conventionally Fractionated Radiotherapy for Locally Advanced Lung Cancer.
McFarlane MR; Hochstedler KA; Laucis AM; Sun Y; Chowdhury A; Matuszak MM; Hayman J; Bergsma D; Boike T; Kestin L; Movsas B; Grills I; Dominello M; Dess RT; Schonewolf C; Spratt DE; Pierce L; Paximadis P; Jolly S; Schipper M;
Int J Radiat Oncol Biol Phys; 2021 Dec; 111(5):1176-1185. PubMed ID: 34314815
[TBL] [Abstract][Full Text] [Related]
28. Exclusion of emphysematous lung from dose-volume estimates of risk improves prediction of radiation pneumonitis.
Uchida Y; Tsugawa T; Tanaka-Mizuno S; Noma K; Aoki K; Shigemori W; Nakagawa H; Kinose D; Yamaguchi M; Osawa M; Ogawa E; Nakano Y
Radiat Oncol; 2017 Oct; 12(1):160. PubMed ID: 28969651
[TBL] [Abstract][Full Text] [Related]
29. New dose constraint reduces radiation-induced fatal pneumonitis in locally advanced non-small cell lung cancer patients treated with intensity-modulated radiotherapy.
Khalil AA; Hoffmann L; Moeller DS; Farr KP; Knap MM
Acta Oncol; 2015; 54(9):1343-9. PubMed ID: 26198657
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancer.
Yang J; Xu T; Gomez DR; Yuan X; Nguyen QN; Jeter M; Song Y; Hahn S; Liao Z
Oncotarget; 2017 Jun; 8(26):43080-43090. PubMed ID: 28574846
[TBL] [Abstract][Full Text] [Related]
31. Framework for radiation pneumonitis risk stratification based on anatomic and perfused lung dosimetry.
Dhami G; Zeng J; Vesselle HJ; Kinahan PE; Miyaoka RS; Patel SA; Rengan R; Bowen SR
Strahlenther Onkol; 2017 May; 193(5):410-418. PubMed ID: 28255667
[TBL] [Abstract][Full Text] [Related]
32. [Pneumonitis after radiotherapy of bronchial carcinoma: incidence and influencing factors].
Schraube P; Schell R; Wannenmacher M; Drings P; Flentje M
Strahlenther Onkol; 1997 Jul; 173(7):369-78. PubMed ID: 9265259
[TBL] [Abstract][Full Text] [Related]
33. Correlation of Functional Lung Heterogeneity and Dosimetry to Radiation Pneumonitis using Perfusion SPECT/CT and FDG PET/CT Imaging.
Lee HJ; Zeng J; Vesselle HJ; Patel SA; Rengan R; Bowen SR
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1255-1264. PubMed ID: 30108002
[TBL] [Abstract][Full Text] [Related]
34. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
[TBL] [Abstract][Full Text] [Related]
35. A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy.
Barriger RB; Forquer JA; Brabham JG; Andolino DL; Shapiro RH; Henderson MA; Johnstone PA; Fakiris AJ
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):457-62. PubMed ID: 21035956
[TBL] [Abstract][Full Text] [Related]
36. Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy.
Fay M; Tan A; Fisher R; Mac Manus M; Wirth A; Ball D
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1355-63. PubMed ID: 15817337
[TBL] [Abstract][Full Text] [Related]
37. Predictive parameters of symptomatic radiation pneumonitis following stereotactic or hypofractionated radiotherapy delivered using volumetric modulated arcs.
Bongers EM; Botticella A; Palma DA; Haasbeek CJ; Warner A; Verbakel WF; Slotman B; Ricardi U; Senan S
Radiother Oncol; 2013 Oct; 109(1):95-9. PubMed ID: 24183862
[TBL] [Abstract][Full Text] [Related]
38. A prospective study of whether radiation pneumonitis is influenced by low-dose irradiated lung volume in primary lung cancer with chronic pulmonary disease.
Niibe Y; Hayakawa K; Masuda N; Yoshimura H
Gan To Kagaku Ryoho; 2007 Feb; 34(2):213-6. PubMed ID: 17301529
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and Characteristics of Pneumonitis Following Irradiation of Breast Cancer.
Werner EM; Eggert MC; Bohnet S; Rades D
Anticancer Res; 2019 Nov; 39(11):6355-6358. PubMed ID: 31704867
[TBL] [Abstract][Full Text] [Related]
40. Dose-volume factors predicting radiation pneumonitis in patients receiving salvage radiotherapy for postlobectomy locoregional recurrent non-small-cell lung cancer.
Uno T; Isobe K; Kawakami H; Ueno N; Kawata T; Yamamoto S; Sekine Y; Iyoda A; Iizasa T; Fujisawa T; Shigematsu N; Ito H
Int J Clin Oncol; 2006 Feb; 11(1):55-9. PubMed ID: 16508730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
